pharmaphorum May 3, 2023
h2o Therapeutics will soon be able to call on the marketing reach of pharma distributor AmerisourceBergen for its app for patients with Parkinson’s disease.
The Turkish digital health company received FDA approval for the Parky app last November as a prescription digital therapeutic (DTx), used to monitor symptoms such as tremors and dyskinesia in Parkinson’s patients in real-time using the Apple Watch.
That came just a few months after AmerisourceBergen launched DTx Connect, a system designed to help physicians order prescription and non-prescription DTx products and handle dispensing and fulfilment. Now h2o has joined other DTx players like Mahana Therapeutics and Videra Health by making its app available on the platform.
Parky was approved on the back of a study...
Today's Sponsors
Today's Sponsor